Pulmonary hypertension refers to elevated blood pressure inside the arteries that feed your lungs, distinct from the systemic pressure measured on your arm. Doctors confirm the diagnosis when the mean pulmonary artery pressure rises above 20 mmHg at rest, and that number only signals the pressure is high. The real question behind pulmonary hypertension causes is what is driving the rise, because treatment hinges on the underlying mechanism, not the reading on the monitor.
This article walks you through the seven main causes of pulmonary hypertension in adults, how each one damages the lung vessels, and how specialists identify which driver is at work in your situation.
Pulmonary Hypertension as a Distinct Vascular Problem
Pressure inside the pulmonary arteries climbs when the small vessels in your lungs narrow, stiffen, or get blocked. That growing resistance forces the right side of your heart to pump harder than it was built to, and over time the muscle wall thickens. Doctors call the failing right ventricle cor pulmonale, and it shows up as swelling in the ankles, a heavy chest during exertion, and fainting spells.
The World Health Organization sorts pulmonary hypertension into five clinical groups based on the underlying mechanism. That grouping matters because a therapy that helps one group can actively harm another. Picking the right path forward means identifying the group first, then matching the approach to it.
How pressure is measured and what the numbers mean
An echocardiogram estimates pulmonary artery pressure and screens for right heart strain as a first step. Right heart catheterization remains the gold standard, threading a thin sensor into the pulmonary artery to record pressure and pulmonary vascular resistance directly. Anything above 20 mmHg at rest qualifies as pulmonary hypertension under current criteria.
Why “regular” hypertension is a different disease
Systemic hypertension raises pressure in the arteries of your arms, legs, and kidneys. Pulmonary hypertension raises pressure only in the vessels feeding your lungs. The two conditions share a name but involve separate circulation systems, separate causes, and separate drug strategies.
Left-Sided Heart Disease, the Most Common Driver
Left heart disease is the leading cause of pulmonary hypertension in adults worldwide. When the left ventricle stiffens or weakens, blood backs up into the left atrium, then into the pulmonary veins, and finally into the pulmonary arteries themselves.
Conditions that stiffen or fail the left heart
Long-standing high blood pressure, coronary artery disease, and aortic or mitral valve problems top the list. Each one raises the pressure the left ventricle must work against, and that extra load transmits backward through the lungs.
The backward pressure cascade
Fluid seeps from overloaded capillaries into the surrounding lung tissue, producing congestion and shortness of breath. The pulmonary arteries sense this elevated downstream pressure and constrict in response, pushing arterial pressure even higher. PH caused by left heart disease falls into WHO Group 2, the largest category worldwide.
| Left heart driver | How it raises lung pressure |
|---|---|
| Long-standing systemic hypertension | Stiffens the left ventricle, raising filling pressure |
| Mitral valve disease | Leaks blood backward into the left atrium |
| Coronary artery disease | Weakens the left ventricle pump over time |
| Aortic stenosis | Forces the left ventricle to push against a narrowed valve |
Lung Diseases and Chronic Hypoxia
Diseases that destroy or scar lung tissue reduce the amount of oxygen that crosses into the bloodstream. Low blood oxygen, a condition called hypoxia, triggers vasoconstriction in the pulmonary arteries, a reflex designed to redirect blood toward better-oxygenated regions of the lung.
Common obstructive and restrictive lung diseases
Chronic obstructive pulmonary disease (COPD) and interstitial lung disease sit at the top of this list. Emphysema breaks down the air sacs themselves, while interstitial disease scars the tissue between them. Both shrink the surface area available for gas exchange and drive chronic hypoxia.
Nighttime breathing problems that add to the load
Obstructive sleep apnea and obesity hypoventilation syndrome drop oxygen levels repeatedly during sleep. The repetitive dips trigger the same vasoconstrictive reflex as chronic lung disease, raising pulmonary artery pressure night after night. PH caused by lung disease or hypoxia falls into WHO Group 3.
Sleep apnea is a frequent hidden contributor to pulmonary hypertension, and treating it can sometimes lower pulmonary pressures without other interventions.
Blood Clots and Chronic Thromboembolic Disease
Some pulmonary emboli never fully dissolve. The residual scar tissue narrows or blocks segments of the pulmonary arteries, raising resistance even when oxygen levels stay normal. This condition has its own name: chronic thromboembolic pulmonary hypertension (CTEPH), and it sits in WHO Group 4.
Why CTEPH is uniquely treatable
Unlike most forms of pulmonary hypertension, CTEPH can sometimes be cured with surgery. Pulmonary thromboendarterectomy physically removes the scarred clot material from the pulmonary arteries, restoring flow. Patients who cannot have surgery may benefit from a catheter-based procedure called balloon pulmonary angioplasty.
Warning signs after a clot
Persistent or worsening shortness of breath weeks to months after a pulmonary embolism deserves a dedicated CTEPH evaluation. A V/Q scan remains the standard screening test, and a positive result leads to pulmonary angiography to map the blockages. Many cases are missed because the symptoms look like deconditioning or anxiety.
Any patient with unexplained breathlessness after a confirmed pulmonary embolism should ask about CTEPH screening rather than accepting the symptom as normal recovery.
Pulmonary Arterial Hypertension and Its Triggers
Active remodeling and progressive narrowing of the small pulmonary arteries defines this serious form of high blood pressure. The vessel walls thicken, smooth muscle multiplies, and the channel for blood shrinks. PAH defines WHO Group 1, and its causes are wide-ranging.
Connective tissue diseases as leading triggers
Scleroderma, also known as systemic sclerosis, ranks first among connective tissue diseases tied to PAH development. Lupus, mixed connective tissue disease, and rheumatoid arthritis can also drive vessel remodeling. Scleroderma patients are screened regularly because PAH is a leading cause of death in that group.
Drugs, toxins, and infections that induce PAH
Specific weight-loss medications, methamphetamine, and select chemotherapy agents have all been documented as triggers. HIV infection raises the risk as well. Congenital heart disease with unrepaired left-to-right shunts can lead to Eisenmenger syndrome, a severe form of PAH where shunt flow reverses direction.
Rarer inherited and structural causes also drive PAH, sometimes through pathways that look nothing like the typical triggers.
- Connective tissue disease: scleroderma, lupus, mixed connective tissue disease
- Drugs and toxins: methamphetamine, certain anorexigens, some chemotherapies
- Infections: HIV and certain parasites
- Congenital heart disease: unrepaired shunts leading to Eisenmenger syndrome
- Portal hypertension: advanced liver disease with portopulmonary hypertension
Less Common and Multifactorial Causes
Several conditions contribute to PH through overlapping mechanisms that do not fit cleanly into the other groups. WHO Group 5 collects these multifactorial cases, and identifying the right driver often requires a specialist workup.
Blood disorders and chronic hemolysis
Sickle cell disease and other hemoglobinopathies destroy red blood cells continuously. Free hemoglobin in the bloodstream mops up nitric oxide, a key vasodilator, leaving pulmonary vessels prone to constriction. Chronic anemia also forces the heart to push higher volumes with each beat.
Kidney disease and metabolic contributors
Chronic kidney disease brings fluid overload, vascular stiffness, and altered mineral metabolism, all of which stress the right heart. Thyroid disorders, sarcoidosis, and certain rare storage diseases round out the list. Pinpointing contributing factors in Group 5 typically combines imaging, blood tests, and sometimes biopsy.
Because these categories overlap so heavily, clinicians rely on a stepwise workup rather than guesswork to classify each case.
| Group 5 driver | Primary mechanism |
|---|---|
| Sickle cell disease | Chronic hemolysis, nitric oxide depletion |
| Chronic kidney disease | Volume overload, vascular calcification |
| Sarcoidosis | Lung infiltration plus direct vessel involvement |
| Thyroid disease | High-output state plus vascular effects |
How Doctors Pin Down the Underlying Cause
Finding the driver takes a stepwise workup. Your cardiologist or pulmonologist starts broad and narrows toward the specific mechanism behind the pulmonary hypertension causes in your case.
The role of echocardiography
Echocardiography estimates pulmonary artery pressure and shows how the right ventricle is coping. It can also spot valve disease, shunts, and left heart dysfunction that point toward a specific WHO group. The reading is an estimate, not a diagnosis.
Right heart catheterization as the gold standard
Direct pressure measurement through a catheter threaded into the right heart chambers provides definitive confirmation. It also calculates pulmonary vascular resistance and tests whether the vessels still respond to vasodilators, which guides therapy in PAH. Most treatment algorithms hinge on numbers only this procedure can deliver.
Imaging, lung function, and clot evaluation
A chest CT scans for interstitial lung disease and emphysema. Pulmonary function tests measure how well the lungs move air and gas. A V/Q scan looks for chronic clots pointing toward CTEPH. Blood tests screen for connective tissue disease, HIV, liver dysfunction, and thyroid abnormalities. NIH-supported protocols bundle these into a structured evaluation that maps cleanly to the five WHO groups.
Expect the workup to take several visits and to include tests that feel unrelated to your lungs, because the right heart, kidneys, liver, and immune system all sit in the causal chain.
Bottom Line
Pulmonary hypertension is a syndrome, not a single disease. Left heart disease drives most adult cases, but lung disease, chronic clots, PAH-specific triggers, and multifactorial disorders each demand different responses. Pinpointing the underlying cause with echocardiography, right heart catheterization, and targeted testing is the only path to a treatment plan that addresses the real driver rather than the pressure reading alone.
FAQ
What is the most common cause of pulmonary hypertension in adults?
Left-sided heart disease dominates globally, responsible for the majority of adult cases classified under WHO Group 2.
Can pulmonary hypertension develop later in life?
Yes. Pulmonary hypertension can develop at any age, and risk rises with conditions such as heart failure, valve disease, lung disease, and recurrent blood clots.
Is pulmonary hypertension caused by heart or lung problems?
It can be caused by either, depending on the underlying condition. Heart failure and valve disease sit on one side, while COPD, interstitial lung disease, and sleep apnea sit on the other.
How does pulmonary hypertension differ from regular high blood pressure?
Regular hypertension affects the systemic arteries throughout your body, while pulmonary hypertension affects only the arteries feeding your lungs, and the two require different treatments.
What are the five groups of pulmonary hypertension classification?
The five WHO groups are PAH, PH due to left heart disease, PH due to lung disease or hypoxia, chronic thromboembolic PH, and PH with unclear or multifactorial mechanisms.
What medical conditions lead to pulmonary hypertension?
Heart failure, mitral valve disease, COPD, interstitial lung disease, sleep apnea, recurrent pulmonary emboli, scleroderma, sickle cell disease, and certain drug exposures are leading causes.
